Table 4.
Medians and ranges (min–max) for age, results of CBC, and PTT for the control population and subgroups of the study population. Also shown is the number of cats with results outside the reference interval for each subgroup
| Cats | Age (years) | HCT (%) | Νeutrophils/μL | Lymphocytes/μL | PTT (sec) |
|---|---|---|---|---|---|
| Group (N) (S/A) | Median (Range) | Median (Range) (n) | Median (Range) (n) | Median (Range) (n) | Median (Range) (n) |
| Ctrl (8) (0/8) | 2a (1–5) |
35.4a (30–42.3) (0) |
4,810a (3,151–10,550) (0) |
3,951a (1,576–6,955) (0) |
92a (78–118) (0) |
| IBD (13) (8/5) | 3.5b (1–16) |
27.5b (21.9–42.2) (4) |
5233a (2,194–20,604) (5) |
2,093b,c (330–8,337) (5) |
92a (68–111) (0) |
| Ch (6) (2/4) | 3.5b (3–10) |
31.3a,b (28.4–34.5) (0) |
10,663b (3,318–25,281) (2) |
3,756a,b (1,872–6,637) (0) |
104a,b (65–110) (0) |
| IBD+Ch (16) (6/10) | 3.5b (1–11) |
31.3a,b (19.3–39.9) (2) |
9,267b (943–17,620) (5) |
1,904c (597–4,304) (4) |
84a (72–401) (1) |
| IBD+Ch+P (8) (8/0) | 7.5c (3–14) |
29.2a,b (7.9–40.5) (3) |
7,103a,b (3,060–26,193) (3) |
2,212a,b,c (141–12,193) (5) |
118b (92–401) (3) |
| Reference interval | – | 24–46 | 3,140–12,520 | 1,310–7,460 | 65–119 |
| MSSDO0.05 | 1.5 | 7.9 | 4,034 | 1,852 | 25.5 |
| Kruskal‐Wallis P | .007 | .062 | .094 | .021 | .048 |
MSSDO: minimum statistically significant difference observed at a significance level P = .05
a, b, c: in the same column of the table, medians followed by common letter do not differ significantly, according to the results of a series of Mann‐Whitney tests. Statistically significant differences exist between medians followed by different superscript letters.
Ctrl: controls.
IBD: cats with histopathological evidence of idiopathic inflammatory bowel disease.
Ch: cats with histopathological evidence of cholangitis.
IBD+Ch: cats with histopathological evidence of IBD and cholangitis.
IBD+Ch+P: cats with histopathological evidence of IBD, cholangitis, and pancreatitis.
S/A: symptomatic/asymptomatic cats in each subgroup.
HCT: hematocrit.
PTT: partial thromboplastine time.